Seres Therapeutics Inc. (MCRB) is priced at $5.80 after the most recent trading session. At the very opening of the session, the stock price was $5.48 and reached a high price of $5.825, prior to closing the session it reached the value of $5.57. The stock touched a low price of $5.39.Recently in News on March 9, 2023, Seres Therapeutics to Participate in Oppenheimer 33rd Annual Healthcare Conference. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will provide a corporate presentation at the Oppenheimer 33rd Annual Healthcare Conference on Wednesday, March 15, 2023 at 8:40 a.m. ET. You can read further details here
Seres Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.49 on 11/01/22, with the lowest value was $2.50 for the same time period, recorded on 06/16/22.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
Seres Therapeutics Inc. (MCRB) full year performance was -12.78%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Seres Therapeutics Inc. shares are logging -38.88% during the 52-week period from high price, and 132.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.50 and $9.49.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 802648 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Seres Therapeutics Inc. (MCRB) recorded performance in the market was 3.57%, having the revenues showcasing -10.77% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 728.07M, as it employees total of 431 workers.
Market experts do have their say about Seres Therapeutics Inc. (MCRB)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.02, with a change in the price was noted -0.37. In a similar fashion, Seres Therapeutics Inc. posted a movement of -6.00% for the period of last 100 days, recording 842,091 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MCRB is recording 4.73 at the time of this writing. In addition, long term Debt to Equity ratio is set at 4.69.
Technical breakdown of Seres Therapeutics Inc. (MCRB)
Raw Stochastic average of Seres Therapeutics Inc. in the period of last 50 days is set at 71.97%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 71.97%. In the last 20 days, the company’s Stochastic %K was 55.56% and its Stochastic %D was recorded 44.19%.
Bearing in mind the latest performance of Seres Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 3.57%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -13.95%, alongside a downfall of -12.78% for the period of the last 12 months. The shares increased approximately by -2.36% in the 7-day charts and went down by 7.61% in the period of the last 30 days. Common stock shares were lifted by -10.77% during last recorded quarter.
